Bristol Myers Squibb today announced Week 52 data from the pivotal Phase 3 POETYK PsA-1 trial further confirming the efficacy and safety of Sotyktu (deucravacitinib) in adults with active psoriatic ...

Topline results and additional data from the pivotal SynAIRgy and LunAIRo Phase 3 studies – the largest clinical program of an investigational ...

AURORA, Colo., Oct. 1, 2025 /PRNewswire/ -- RheumaGen, Inc., a cell and gene therapy company engineering a new class of therapeutics for major autoimmune diseases, today announced that a human ...

Rumor mill: Intel's upcoming Panther Lake CPU lineup has been making headlines as of late, particularly after the company shared an architectural overview with journalists during last month's Tech ...

AI tools also played a crucial role in precision targeting during Operation Sindoor, Lt Gen Sahni said The Indian Army used artificial intelligence (AI) tools in a ...

Leuven, Belgium. October 6, 2025. Onco3R Therapeutics, a clinical-stage immunology and oncology biotech company dedicated to transforming patients’ lives with best-in-class medicines, today announced ...

MONTREAL, Oct. 1, 2025 /CNW/ - PRO Real Estate Investment Trust ("PROREIT" or the "REIT") (TSX: PRV.UN) today announced that it has completed the sale of 12 non-core retail properties totalling ...

Gaming Laptops Best graphics card for laptops in 2025: the mobile GPUs I'd want in my next gaming laptop Processors Best CPU for gaming in 2025: These are the chips I recommend for gaming, ...

Net income of $21.9 million, or $1.13 per diluted share, for the three months ended September 30, 2025 compared to net income of $19.4 million, ...

The agency responsible for delivering AUKUS has spent five times what it first planned for consultants to review its operations. The agency has struggled with its culture since it was created, ranking ...